Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension.
Grabowski K, Herlan L, Witten A, Qadri F, Eisenreich A, Lindner D, Schädlich M, Schulz A, Subrova J, Mhatre KN, Primessnig U, Plehm R, van Linthout S, Escher F, Bader M, Stoll M, Westermann D, Heinzel FR, Kreutz R. Grabowski K, et al. Among authors: van linthout s. Hypertens Res. 2022 Feb;45(2):292-307. doi: 10.1038/s41440-021-00826-8. Epub 2021 Dec 16. Hypertens Res. 2022. PMID: 34916661 Free PMC article.
Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.
Westermann D, Rutschow S, Van Linthout S, Linderer A, Bücker-Gärtner C, Sobirey M, Riad A, Pauschinger M, Schultheiss HP, Tschöpe C. Westermann D, et al. Among authors: van linthout s. Diabetologia. 2006 Oct;49(10):2507-13. doi: 10.1007/s00125-006-0385-2. Epub 2006 Aug 26. Diabetologia. 2006. PMID: 16937126
Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.
Savvatis K, van Linthout S, Miteva K, Pappritz K, Westermann D, Schefold JC, Fusch G, Weithäuser A, Rauch U, Becher PM, Klingel K, Ringe J, Kurtz A, Schultheiss HP, Tschöpe C. Savvatis K, et al. Among authors: van linthout s. PLoS One. 2012;7(7):e41047. doi: 10.1371/journal.pone.0041047. Epub 2012 Jul 17. PLoS One. 2012. PMID: 22815907 Free PMC article.
Reversible transition from a hypertrophic to a dilated cardiomyopathy.
Spillmann F, Kühl U, Van Linthout S, Dominguez F, Escher F, Schultheiss HP, Pieske B, Tschöpe C. Spillmann F, et al. Among authors: van linthout s. ESC Heart Fail. 2016 Jun;3(2):138-142. doi: 10.1002/ehf2.12072. Epub 2015 Dec 9. ESC Heart Fail. 2016. PMID: 27774273 Free PMC article.
Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD, Van Linthout S, Westermann D, Lindhorst R, Sandek A, Ernst S, Bobenko A, Kasner M, Spillmann F, González A, López B, Ravassa S, Pieske B, Paulus WJ, Díez J, Edelmann F, Tschöpe C. Trippel TD, et al. Among authors: van linthout s. Eur J Heart Fail. 2018 Mar;20(3):460-470. doi: 10.1002/ejhf.960. Epub 2017 Sep 11. Eur J Heart Fail. 2018. PMID: 28891228 Free article. Clinical Trial.
147 results